Tumour necrosis factor alpha blocking agents in refractory adult Still's disease: an observational study of 20 cases (Q35555229)

8 August 2017

title

Tumour necrosis factor alpha blocking agents in refractory adult Still's disease: an observational study of 20 cases (English)

1 reference

8 August 2017

0 references

1 reference

B Fautrel

1

1 reference

8 August 2017

J Sibilia

2

1 reference

8 August 2017

X Mariette

3

1 reference

8 August 2017

B Combe

4

1 reference

8 August 2017

Club Rhumatismes et Inflammation

5

1 reference

8 August 2017

language of work or name

English

0 references

publication date

7 June 2004

1 reference

Annals of the Rheumatic Diseases

8 August 2017

published in

1 reference

8 August 2017

volume

64

1 reference

8 August 2017

issue

2

1 reference

8 August 2017

page(s)

262-266

1 reference

Side effects of anti-TNF therapy: current knowledge.

8 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755371

Infliximab for the treatment of rheumatoid arthritis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755371

Etanercept in the treatment of adult patients with Still's disease

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755371

Tumor necrosis factor-alpha antagonists for the treatment of rheumatic diseases

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755371

Safety and efficacy of disease-modifying anti-rheumatic agents: focus on the benefits and risks of etanercept

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755371

Decline after immobilisation and recovery after remobilisation of synovial fluid IL1, TIMP, and chondroitin sulphate levels in young beagle dogs

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755371

Percentage of glycosylated serum ferritin remains low throughout the course of adult onset Still's disease

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755371

Corticosteroid sparing effect of low dose methotrexate treatment in adult Still's disease.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755371

Methotrexate treatment in patients with adult onset Still's disease--retrospective study of 13 Japanese cases

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755371

Adult Still's disease. Part II. Management, outcome, and prognostic factors

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755371

Adult Still's disease: part I. Manifestations and complications in sixty-five cases in France

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755371

Epidemiology of adult Still's disease: estimate of the incidence by a retrospective study in west France

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755371

Still's disease in the adult

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755371

Adult-onset Still's disease. Clinical course and outcome

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755371

Adult-onset Still's disease; clinical and laboratory features, treatment and progress of 45 cases

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755371

Adult Still's disease: review of 228 cases from the literature

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755371

Adult onset Still's disease: experience in 23 patients and literature review with emphasis on organ failure

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755371

Adult Still's disease: a multicenter survey of Japanese patients.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755371

Adult Still's disease: manifestations, disease course, and outcome in 62 patients

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755371

Treatment of fulminant adult Still's disease with intravenous pulse methylprednisolone therapy

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755371

Fever in adult onset Still's disease. Response to methotrexate

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755371

Low dose methotrexate treatment in adult Still's disease

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755371

Preliminary criteria for classification of adult Still's disease

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755371

Retrobulbar optic neuritis associated with infliximab.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755371

Infliximab in the treatment of adult Still's disease refractory to conventional therapy

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755371

Intravenous immunoglobulin in adult Still's disease refractory to non-steroidal anti-inflammatory drugs.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755371

Estimated prevalence and incidence of adult Still's disease: findings by a nationwide epidemiological survey in Japan.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755371

[Treatment of Still disease in adults with intravenous immunoglobulins].

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755371

Anti-TNF-alpha-induced systemic lupus syndrome

26 September 2018

1 reference

12 December 2020

Drug-induced systemic lupus erythematosus associated with etanercept therapy

1 reference

12 December 2020

Cyclosporin A in the treatment of adult onset Still's disease

1 reference

12 December 2020

Cyclosporin A in the treatment of adult Still's disease

1 reference

12 December 2020

Intravenous methylprednisolone pulse therapy in Still's disease

1 reference

12 December 2020

Identifiers

DOI

10.1136/ARD.2004.024026

1 reference

8 August 2017

1 reference

8 August 2017

1 reference